Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motoki Yano

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 21, 2019
Tumour size determines both recurrence-free survival and disease-specific survival after surgical treatment for thymomaMeinoshin Okumura, Ichiro Yoshino, Motoki Yano, et al.
Lung Cancer (Amsterdam, Netherlands)|February 19, 2017
A prospective, multi-institutional phase II study of induction chemoradiotherapy followed by surgery in patients with non-small cell lung cancer involving the chest wall (CJLSG0801)Koji Kawaguchi, Kohei Yokoi, Hiroshi Niwa, et al.
Japanese Journal of Cancer Research : Gann|August 1, 2002
Ratio of expression of p16INK4a to p14ARF correlates with the progression of non-small cell lung cancerSatoru Moriyama, Yoshiaki Nakashima, Motoki Yano, et al.
The Annals of Thoracic Surgery|August 12, 2014
Trimodality therapy for lung cancer with chest wall invasion: initial results of a phase II studyKoji Kawaguchi, Kohei Yokoi, Hiroshi Niwa, et al.
Journal of Cancer Research and Clinical Oncology|May 15, 2008
A novel EGFR mutation D1012H and polymorphism at exon 25 in Japanese lung cancerHidefumi Sasaki, Katsuhiro Okuda, Minoru Takada, et al.
Lung Cancer (Amsterdam, Netherlands)|August 8, 2006
L858R EGFR mutation status correlated with clinico-pathological features of Japanese lung cancerHidefumi Sasaki, Katsuhiko Endo, Minoru Takada, et al.
The Journal of Surgical Research|June 11, 2008
EGFR polymorphism of the kinase domain in Japanese lung cancerHidefumi Sasaki, Katsuhiko Endo, Minoru Takada, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2007
EGFR exon 20 insertion mutation in Japanese lung cancerHidefumi Sasaki, Katsuhiko Endo, Minoru Takada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
EGFR Mutation status in Japanese lung cancer patients: genotyping analysis using LightCyclerHidefumi Sasaki, Katsuhiko Endo, Akimitsu Konishi, et al.
Molecular and Clinical Oncology|July 7, 2018
The relationship between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase, excision repair cross-complementation group 1 and class III β-tubulin, and the therapeutic effect of S-1 or carboplatin plus paclitaxel in non-small-cell lung cancerKatsuhiro Okuda, Tsutomu Tatematsu, Motoki Yano, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 21, 2019
Tumour size determines both recurrence-free survival and disease-specific survival after surgical treatment for thymomaMeinoshin Okumura, Ichiro Yoshino, Motoki Yano, et al.
Lung Cancer (Amsterdam, Netherlands)|February 19, 2017
A prospective, multi-institutional phase II study of induction chemoradiotherapy followed by surgery in patients with non-small cell lung cancer involving the chest wall (CJLSG0801)Koji Kawaguchi, Kohei Yokoi, Hiroshi Niwa, et al.
Japanese Journal of Cancer Research : Gann|August 1, 2002
Ratio of expression of p16INK4a to p14ARF correlates with the progression of non-small cell lung cancerSatoru Moriyama, Yoshiaki Nakashima, Motoki Yano, et al.
The Annals of Thoracic Surgery|August 12, 2014
Trimodality therapy for lung cancer with chest wall invasion: initial results of a phase II studyKoji Kawaguchi, Kohei Yokoi, Hiroshi Niwa, et al.
Journal of Cancer Research and Clinical Oncology|May 15, 2008
A novel EGFR mutation D1012H and polymorphism at exon 25 in Japanese lung cancerHidefumi Sasaki, Katsuhiro Okuda, Minoru Takada, et al.
Lung Cancer (Amsterdam, Netherlands)|August 8, 2006
L858R EGFR mutation status correlated with clinico-pathological features of Japanese lung cancerHidefumi Sasaki, Katsuhiko Endo, Minoru Takada, et al.
The Journal of Surgical Research|June 11, 2008
EGFR polymorphism of the kinase domain in Japanese lung cancerHidefumi Sasaki, Katsuhiko Endo, Minoru Takada, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2007
EGFR exon 20 insertion mutation in Japanese lung cancerHidefumi Sasaki, Katsuhiko Endo, Minoru Takada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
EGFR Mutation status in Japanese lung cancer patients: genotyping analysis using LightCyclerHidefumi Sasaki, Katsuhiko Endo, Akimitsu Konishi, et al.
Molecular and Clinical Oncology|July 7, 2018
The relationship between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase, excision repair cross-complementation group 1 and class III β-tubulin, and the therapeutic effect of S-1 or carboplatin plus paclitaxel in non-small-cell lung cancerKatsuhiro Okuda, Tsutomu Tatematsu, Motoki Yano, et al.
Pageof 15